Skip to content
Tuesday 1 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
0.00%
DAX
26,258.11
-1.17%
CAC 40
8,334.50
-0.79%
STOXX 50
6,420.16
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Tuesday 01 October 2013 3:42 am

International report slams war on drugs

By: Peter Spence

Add as a preferred source on Google

The International Centre for Science in Drug Policy (ICSDP) has produced a report highly critical of the war on drugs. The report found that in the last twenty years the price for drugs has dramatically declined and purity has increased, despite greater levels of interdiction than at any point in history. The authors of the report suggest that problems related to recreational drug use should be treated as a public health issue instead of a matter for the criminal justice system.

The ICSDP cites the price declines in Europe of 51 per cent for cocaine and 74 per cent for heroin between the years 1990 and 2010, as evidence of the abject failure of law enforcement officials to restrict the supply of drugs. The report was published in the British Medical Journal Open and drew its evidence from seven international drug surveillance systems.

Dr Evan Wood, scientific chairman of the ICSDP, said:

We should look to implement policies that place community health and safety at the forefront of our efforts, and consider drug use a public health issue rather than a criminal justice issue.

With the recognition that efforts to reduce drug supply are unlikely to be successful, there is a clear need to scale up addiction treatment and other strategies that can effectively reduce drug-related harm.

The report concluded:

These findings suggest that expanding efforts at controlling the global illegal drug market through law enforcement are failing.

The study comes in the wake of an Observer article penned by Chief Constable Mike Barton, of Durham Police, advocating the decriminalisation of class A drugs. Mr Barton wrote on Saturday that decriminalisation would provide a safer environment for drug users and would reduce the power of organised crime:

Not all crime gangs raise income through selling drugs, but most of them do in my experience. So offering an alternative route of supply to users cuts their income stream off.

The Home Office responded to the latest call for a rethink of drug policy by reiterating its current position with regards to drugs:

We must help individuals who are dependent by treatment, while ensuring law enforcement protects society by stopping the supply and tackling the organised crime that is associated with the drugs trade.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Morning Wire Content

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jaguar reveals the Type 01’s screen-free interior

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • City firms mandate phone and face-to-face comms bootcamps for Gen Z lawyers

  • Jamie Vardy bags Bundesliga rights as he steps up streaming war with Neville and Lineker

More from Morning Wire

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Sweeping job cuts at GSK to fund £400m Cambridge campus

    Pharma
    Modern GSK Cambridge campus buildings with sky bridge, green spaces, and people walking and cycling.
  • Terry Smith dubs weight-loss giant Novo Nordisk ‘investment disaster’

    Investing
    Terry Smith, founder of Fundsmith, speaking at a business conference, wearing a suit and tie, with a focused expression.
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • Whey and weight-loss drugs to eat into Applied Nutrition profit

    Retail
    Woman lifting dumbbells with a trainer in a busy gym, promoting fitness and health
  • ViiV Healthcare to present phase IIIb data comparing Dovato with Biktarvy in treatment-naïve adults; alongside INSTI-powered long-acting injectable innovation at AIDS 2026

    Business Wire
  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
  • Promega Achieves 100% Renewable Electricity Across Global Operations

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook